Literature DB >> 31845200

Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria.

Wen-Qing Xie1,2, Ge-Lei Xiao3, Yi-Bin Fan4, Miao He1,2, Shan Lv5, Yu-Sheng Li6,7.   

Abstract

Sarcopenic obesity (SO) refers to an obesity disease accompanied by low skeletal muscle quality, strength and/or function, which is more common in the elderly and seriously affects their quality of life and can lead to falls, unstable walking, balance disorders and fractures in the elderly. The increase in aging populations and the various health problems and medical costs associated with SO have aroused widespread concern in society. However, the pathogenesis of SO has not been fully clarified and the diagnostic criteria are not uniform, meaning that there are inconsistent data on the prevalence of SO and the potential correlation between SO and health outcomes. Therefore, we review the research progress on delineating the pathogenesis and diagnostic criteria of SO, to assist in the early diagnosis and evaluation of SO and subsequent interventions.

Entities:  

Keywords:  Diagnostic criteria; Obesity; Pathogenesis; Sarcopenia; Sarcopenic obesity

Mesh:

Year:  2019        PMID: 31845200     DOI: 10.1007/s40520-019-01435-9

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  31 in total

1.  Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.

Authors:  W Kemmler; S von Stengel; K Engelke; C Sieber; E Freiberger
Journal:  Osteoporos Int       Date:  2015-08-29       Impact factor: 4.507

2.  Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study.

Authors:  Seok Won Park; Bret H Goodpaster; Elsa S Strotmeyer; Lewis H Kuller; Robert Broudeau; Candace Kammerer; Nathalie de Rekeneire; Tamara B Harris; Ann V Schwartz; Frances A Tylavsky; Yong-wook Cho; Anne B Newman
Journal:  Diabetes Care       Date:  2007-03-15       Impact factor: 19.112

3.  Associations between Sarcopenic Obesity and Cognitive Impairment in Elderly Chinese Community-Dwelling Individuals.

Authors:  H Wang; S Hai; Y X Liu; L Cao; Y Liu; P Liu; Y Yang; B R Dong
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

4.  Progress of sarcopenia research.

Authors:  Kazuho Sakamoto
Journal:  Nihon Yakurigaku Zasshi       Date:  2017

Review 5.  Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.

Authors:  Alexander Kalinkovich; Gregory Livshits
Journal:  Ageing Res Rev       Date:  2016-10-01       Impact factor: 10.895

Review 6.  Sarcopenic obesity: definition, cause and consequences.

Authors:  Sari Stenholm; Tamara B Harris; Taina Rantanen; Marjolein Visser; Stephen B Kritchevsky; Luigi Ferrucci
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-11       Impact factor: 4.294

7.  Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.

Authors:  John A Batsis; Todd A Mackenzie; Jonathan D Jones; Francisco Lopez-Jimenez; Stephen J Bartels
Journal:  Clin Nutr       Date:  2016-04-07       Impact factor: 7.324

8.  Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity.

Authors:  Francesco Bellanti; Antonino D Romano; Aurelio Lo Buglio; Valeria Castriotta; Giuseppe Guglielmi; Antonio Greco; Gaetano Serviddio; Gianluigi Vendemiale
Journal:  Maturitas       Date:  2017-12-05       Impact factor: 4.342

9.  Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.

Authors:  Laura D Baker; Suzanne M Barsness; Soo Borson; George R Merriam; Seth D Friedman; Suzanne Craft; Michael V Vitiello
Journal:  Arch Neurol       Date:  2012-11

10.  Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study.

Authors:  Stefanos Tyrovolas; Ai Koyanagi; Beatriz Olaya; Jose Luis Ayuso-Mateos; Marta Miret; Somnath Chatterji; Beata Tobiasz-Adamczyk; Seppo Koskinen; Matilde Leonardi; Josep Maria Haro
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-10-07       Impact factor: 12.910

View more
  12 in total

1.  Farnesol-Loaded Nanoliposomes Inhibit Inflammatory Gene Expression in Primary Human Skeletal Myoblasts.

Authors:  Eva Mückter; Maria Lozoya; Aline Müller; Volkmar Weissig; Mahtab Nourbakhsh
Journal:  Biology (Basel)       Date:  2022-05-02

Review 2.  The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.

Authors:  Erika Aparecida Silveira; Rômulo Roosevelt da Silva Filho; Maria Claudia Bernardes Spexoto; Fahimeh Haghighatdoost; Nizal Sarrafzadegan; Cesar de Oliveira
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

3.  Trajectories of Body Composition during Advanced Aging in Consideration of Diet and Physical Activity: A 20-Year Longitudinal Study.

Authors:  Alexandra Jungert; Gerrit Eichner; Monika Neuhäuser-Berthold
Journal:  Nutrients       Date:  2020-11-25       Impact factor: 5.717

4.  Sterol metabolism and protein metabolism are differentially correlated with sarcopenia in Asian Chinese men and women.

Authors:  Chun-Wei Li; Kang Yu; Ng Shyh-Chang; Guo-Xun Li; Song-Lin Yu; Hui-Jun Liu; Bo Yang; Zi-Yao Li; Yong-Jie Zhao; Long-Yu Xu; Jing Xu; Ling-Juan Jiang; Rong-Ji Liu; Xin-Yuan Zhang; Shao-Fei Li; Xiao-Wei Zhang; Hai-Yan Xie; Kang Li; Yi-Xiang Zhan; Min Cui; Hang-Bo Tao; Yao Li; Gao-Shan Liu; Ke-Min Ni; Dong-Jing Li
Journal:  Cell Prolif       Date:  2021-02-20       Impact factor: 6.831

5.  Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria.

Authors:  Francesca Remelli; Elisa Maietti; Pasquale Abete; Giuseppe Bellelli; Mario Bo; Antonio Cherubini; Francesco Corica; Mauro Di Bari; Marcello Maggio; Maria Rosaria Rizzo; Andrea P Rossi; Francesco Landi; Stefano Volpato
Journal:  Aging Clin Exp Res       Date:  2021-08-16       Impact factor: 3.636

Review 6.  The Critical Role of Oxidative Stress in Sarcopenic Obesity.

Authors:  Andrea Gonzalez; Felipe Simon; Oscar Achiardi; Cristian Vilos; Daniel Cabrera; Claudio Cabello-Verrugio
Journal:  Oxid Med Cell Longev       Date:  2021-10-12       Impact factor: 6.543

7.  Sarcopenic Obesity: An Emerging Public Health Problem.

Authors:  Tong Ji; Yun Li; Lina Ma
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

Review 8.  Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments.

Authors:  Mina Wang; Yan Tan; Yifan Shi; Xu Wang; Zehuan Liao; Peng Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-25       Impact factor: 5.555

9.  Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.

Authors:  Qianqian Gao; Kaiyan Hu; Chunjuan Yan; Bing Zhao; Fan Mei; Fei Chen; Li Zhao; Yi Shang; Yuxia Ma; Bin Ma
Journal:  Nutrients       Date:  2021-11-27       Impact factor: 5.717

10.  Free Fatty Acid Species Differentially Modulate the Inflammatory Gene Response in Primary Human Skeletal Myoblasts.

Authors:  Melanie Rauen; Dandan Hao; Aline Müller; Eva Mückter; Leo Cornelius Bollheimer; Mahtab Nourbakhsh
Journal:  Biology (Basel)       Date:  2021-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.